These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 25078909
1. Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles. Negri CE, Gonçalves SS, Xafranski H, Bergamasco MD, Aquino VR, Castro PT, Colombo AL. J Clin Microbiol; 2014 Oct; 52(10):3633-40. PubMed ID: 25078909 [Abstract] [Full Text] [Related]
2. Multilocus Phylogeny and Antifungal Susceptibility of Aspergillus Section Circumdati from Clinical Samples and Description of A. pseudosclerotiorum sp. nov. Siqueira JP, Sutton DA, Gené J, García D, Wiederhold N, Peterson SW, Guarro J. J Clin Microbiol; 2017 Mar; 55(3):947-958. PubMed ID: 28053212 [Abstract] [Full Text] [Related]
3. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B. Escribano P, Peláez T, Recio S, Bouza E, Guinea J. Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886 [Abstract] [Full Text] [Related]
4. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex. Badali H, Fakhim H, Zarei F, Nabili M, Vaezi A, Poorzad N, Dolatabadi S, Mirhendi H. Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417 [Abstract] [Full Text] [Related]
5. Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method. Mello E, Posteraro B, Vella A, De Carolis E, Torelli R, D'Inzeo T, Verweij PE, Sanguinetti M. Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416538 [Abstract] [Full Text] [Related]
6. In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus. Alastruey-Izquierdo A, Cuesta I, Houbraken J, Cuenca-Estrella M, Monzón A, Rodriguez-Tudela JL. Med Mycol; 2010 Feb; 48(1):97-102. PubMed ID: 19296366 [Abstract] [Full Text] [Related]
7. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species. Wang HC, Hsieh MI, Choi PC, Wu CJ. J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391 [Abstract] [Full Text] [Related]
8. Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea. Won EJ, Shin JH, Kim SH, Choi MJ, Byun SA, Kim MN, Lee WG, Lee K, Uh Y, Shin MG, Suh SP. Med Mycol; 2018 Jun 01; 56(4):501-505. PubMed ID: 28992138 [Abstract] [Full Text] [Related]
9. Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran. Xu X, Naseri A, Houbraken J, Akbari F, Wang X, Zhao R, Zhang H, Najafzadeh MJ, Deng S. Sci Rep; 2021 Mar 24; 11(1):6808. PubMed ID: 33762586 [Abstract] [Full Text] [Related]
10. Aspergillus citrinoterreus, a new species of section Terrei isolated from samples of patients with nonhematological predisposing conditions. Guinea J, Sandoval-Denis M, Escribano P, Peláez T, Guarro J, Bouza E. J Clin Microbiol; 2015 Feb 24; 53(2):611-7. PubMed ID: 25502530 [Abstract] [Full Text] [Related]
11. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens. Mohamadnia A, Salehi Z, Namvar Z, Tabarsi P, Pourabdollah-Toutkaboni M, Rezaie S, Marjani M, Moniri A, Abtahian Z, Mahdaviani SA, Mortezaee V, Askari E, Sharifynia S. J Mycol Med; 2020 Sep 24; 30(3):101004. PubMed ID: 32534826 [Abstract] [Full Text] [Related]
12. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Pfaller MA, Messer SA, Hollis RJ, Jones RN, SENTRY Participants Group. Antimicrob Agents Chemother; 2002 Apr 24; 46(4):1032-7. PubMed ID: 11897586 [Abstract] [Full Text] [Related]
13. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns. Castro C, Galán-Sanchez F, Linares MJ, Tejero R, Ruiz M, Serrano ML, Rodríguez-Iglesias M, Martín-Mazuelos E, FUNGAE-IFI Study Group. Med Mycol; 2019 Jun 01; 57(4):412-420. PubMed ID: 30289467 [Abstract] [Full Text] [Related]
14. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Kaya AD, Kiraz N. Mycoses; 2007 Nov 01; 50(6):447-50. PubMed ID: 17944704 [Abstract] [Full Text] [Related]
15. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses. Öz Y, Özdemir HG, Gökbolat E, Kiraz N, Ilkit M, Seyedmousavi S. Mycopathologia; 2016 Apr 01; 181(3-4):225-33. PubMed ID: 26612621 [Abstract] [Full Text] [Related]
16. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China. Zhang L, Wang X, Houbraken J, Mei H, Liao W, Hasimu H, Liu W, Deng S. Mycopathologia; 2020 Jun 01; 185(3):527-535. PubMed ID: 32346838 [Abstract] [Full Text] [Related]
17. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt ME, Pappas PG, Chiller T. J Clin Microbiol; 2009 Oct 01; 47(10):3138-41. PubMed ID: 19675215 [Abstract] [Full Text] [Related]
18. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Espinel-Ingroff A, Diekema DJ, Fothergill A, Johnson E, Pelaez T, Pfaller MA, Rinaldi MG, Canton E, Turnidge J. J Clin Microbiol; 2010 Sep 01; 48(9):3251-7. PubMed ID: 20592159 [Abstract] [Full Text] [Related]